Because IGF-1 LR3 is not clinically approved, safety data in humans is limited
Common side effects include mild nausea, fatigue, headache, or appetite changes, typically subsiding within the first weeks as your body adjusts
Their focus on growth-hormone peptide stacks (CJC-1295, Ipamorelin, Sermorelin) and PT-141 sexual-wellness protocols aligns well with the most in-demand peptide categories in 2026
If fatigue is severe, persistent, or paired with dizziness, weakness, repeated vomiting, or low glucose symptoms, it deserves medical attention
Acknowledgements We would like to thank Medical Experimental Center and Experimental Technology Center at Jinan University
All of our products are manufactured in the USA, FDA-registered, approved, and inspected state-of-the-art facilities, with strict adherence to current Good Manufacturing Practices